APA (7th ed.) Citation

Sprague, S. M., Crawford, P. W., Melnick, J. Z., Strugnell, S. A., Ali, S., Mangoo-Karim, R., . . . Bishop, C. W. (2016). Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease. American journal of nephrology, 44(4), 316. https://doi.org/10.1159/000450766

Chicago Style (17th ed.) Citation

Sprague, Stuart M., Paul W. Crawford, Joel Z. Melnick, Stephen A. Strugnell, Shaukat Ali, Roberto Mangoo-Karim, Sungchun Lee, P Martin Petkovich, and Charles W. Bishop. "Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease." American Journal of Nephrology 44, no. 4 (2016): 316. https://doi.org/10.1159/000450766.

MLA (9th ed.) Citation

Sprague, Stuart M., et al. "Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease." American Journal of Nephrology, vol. 44, no. 4, 2016, p. 316, https://doi.org/10.1159/000450766.